$31 million study to test use of inhaled corticosteroids, azithromycin in asthma treatment

With $31 million in funding from the Patient-Centered Outcomes Research Institute, researchers will investigate the effectiveness of inhaled corticosteroids and azithromycin, used either alone or together, in treating asthma.
The American Academy of Family Physicians (AAFP) and Penn State College of Medicine will collaborate on the Individualizing Treatment for Asthma in Primary Care (iTREAT-PC) study, which will test these interventions.
For 16 months, the researchers will follow more than 3,000 patients aged 12 to 75 years with persistent asthma requiring inhaled steroids for management at 10

With $31 million in funding from the Patient-Centered Outcomes Research Institute, researchers will investigate the effectiveness of inhaled corticosteroids and azithromycin, used either alone or together, in treating asthma.
The American Academy of Family Physicians (AAFP) and Penn State College of Medicine will collaborate on the Individualizing Treatment for Asthma in Primary Care (iTREAT-PC) study, which will test these interventions.
For 16 months, the researchers will follow more than 3,000 patients aged 12 to 75 years with persistent asthma requiring inhaled steroids for management at 10